Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

ATRA $42.90 6.3000 +17.21%
PBYI $239.76 23.7600 +11.00%
NLNK $56.40 4.1400 +7.92%
ARQL $2.24 0.1400 +6.67%
EXEL $2.70 0.1600 +6.30%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

BDSI $10.51 -3.3800 -24.33%
CBMG $36.95 -3.1500 -7.86%
SRNE $11.36 -0.9300 -7.57%
VBLT $5.29 -0.3900 -6.87%
CALA $16.42 -1.0300 -5.90%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

Reimbursement Key to Improving End-of-Life Care

(Medscape Medical News) Mar 20, 2015 - Giving physicians incentives — and compensating them appropriately — will be key to helping the nation improve end-of-life planning and care, said experts gathered at an Institute of Medicine (IOM) forum today.
read article (free registration required) 

Foundation Medicine and Collaborators to Present New Data in 20 Oral and Poster Presentations at the 2015 USCAP Annual Meeting

(NASDAQ) Mar 23, 2015 - Data underscore benefits of leveraging comprehensive genomic profiling to complement standard pathology practices for improving patient outcomes with targeted therapy.
read article 

Highlights from the NCCN 20th Annual Conference Include Expert Roundtables, Presentation of New and Updated Treatment Guidelines

(MarketWatch) Mar 20, 2015 - During this year’s conference, NCCN leadership commemorated two decades of evidence-based decision-making in cancer care with three expert roundtables, as well as presentations on two new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Smoking Cessation and Global Resource Stratification: Cervical Cancer.
read article 

AMP Submits Written Comments to FDA on Next Generation Sequencing Regulation, Emphasizing Need for Consistent and Proper Performance of Tests

(AMP) Mar 23, 2015 - The Association for Molecular Pathology (AMP) submitted written comments on March 20 to the FDA in response to the agency’s request for feedback in association with its February 20, 2015 public workshop entitled, “Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests.”
read press release 

State Oncology Societies Join ASCO's Call on Congress to Replace SGR Formula

(ASCO) Mar 23, 2015 - In a show of solidarity, state oncology societies from across the United States today joined the American Society of Clinical Oncology (ASCO) in its call on Congress to repeal Medicare's Sustainable Growth Rate (SGR) formula before the current payment patch expires at the end of the month.
read press release 

Kleiner Perkins’s Beth Seidenberg Says Immunotherapy Is Biotech Powerhouse

(Wall Street Journal/Venture Capital Dispatch blog) Mar 23, 2015 - Dr. Beth Seidenberg talked to Venture Capital Dispatch about why immunotherapy, especially as a treatment for cancer, has become one of the hottest areas in biotech.
read article (paid subscription required) 

ImmunoGen Surges on $440M Takeda Deal For “Smart Bomb” Cancer Drugs

(Xconomy Boston) Mar 23, 2015 - ImmunoGen’s claim to fame has been its role in making a “smart bomb” cancer drug that Roche subsidiary Genentech sells for breast cancer. Now it’s hoping for a repeat performance with a new partner, Takeda.
read article 

Artificial Sweetener May Help Treat Aggressive Cancers, Study Finds

( Mar 23, 2015 - For years, negative reports have surrounded artificial sweeteners, claiming evidence of everything from being a carcinogen to causing cardiovascular disease. But now new research suggests a popular sugar substitute could lead to new treatments for some of the most common types of cancers.
read article 

Study Demonstrates New Noninvasive Gene Expression Profile Test Predicts Melanoma Risk More Accurately Than AJCC Online Predictor Tool

(MarketWatch) Mar 20, 2015 - Consistent with prior studies, DecisionDx-Melanoma test outperforms AJCC tool in assessing probability of distant metastasis and overall survival.
read article 

Is This a Miracle Cancer Vaccine? Scientists Hail Breakthrough Treatment as a 'Game Changer'

(Daily Mail [UK]) Mar 21, 2015 - Scientists are having extraordinary success treating cancer with new vaccines they believe could be a ‘game-changer’ in the battle against the disease.
read article 

Complementary Therapies Can Boost Survival in Cancer Patients

(Medscape Medical News) Mar 20, 2015 - Complementary and alternative approaches are widely used by cancer patients to help control symptoms, but a new review suggests that some might also improve survival.
read article (free registration required) 

Transperineal Prostate Biopsy 'Well Tolerated,' Study Shows

(Medscape Medical News) Mar 23, 2015 - The newer technique of transperineal biopsy performed under general anesthetic produced scores similar to those obtained with the standard transrectal approach.
read article (free registration required) 

New Potential for Personalised Treatments in Bowel Cancer

(Cancer Research UK) Mar 23, 2015 - Scientists have found that genetic changes in bowel tumours are linked to the way the body’s immune system responds to the cancer, according to research published today (Monday) in the journal Oncoimmunology*.
read press release 

Measuring Response to Leukemia Treatment May Save More Lives

(St. Jude Children's) Mar 20, 2015 - Measuring the concentration of leukemia cells in patient bone marrow during the first 46 days of chemotherapy should help boost survival of young leukemia patients by better matching patients with the right intensity of chemotherapy.
read article 

Tumors Grown in Dishes Could Help Customize Cancer Treatment

(Reuters) Mar 23, 2015 - Experiments conducted at an underground laboratory at Vanderbilt University could prove vital in the fight against cancer. Alex Walsh, a biomedical researcher, is using a laser to make what she calls organoids glow.
read article 

World's Most Popular Weed-killer Labeled 'Probable Carcinogen'

(Chicago Tribune/Associated Press) Mar 23, 2015 - One of the world's most popular weed-killers — and the most widely used kind in the U.S. — has been labeled a probable carcinogen by the International Agency for Research on Cancer.
read article 

The Road to Cancer Treatment Through Clinical Trials

(New York Times/Well blog) Mar 23, 2015 - Although the backbone of today’s successful cancer treatments, clinical trials are poorly understood by the public, often viewed as treating people like guinea pigs instead of as giving them the best chance for survival.
read article 

MEI Pharma Shares Swoon as Cancer Drug Fails Study

(Reuters) Mar 23, 2015 - MEI Pharma lost more than two-thirds of its market value on Monday after the company's cancer drug failed to meet the main goal in a mid-stage study.
read article 

Sanofi and Evotec Seal 250m-Euro Strategic Alliance

(PharmaTimes [UK]) Mar 20, 2015 - Sanofi and Evotec have now concluded negotiations over a five-year strategic alliance giving the German group 250 million Euros, including more than 40 million Euros upfront in cash.
read article 

FDA Panel Backs Glaxo Asthma Drug For Adults, Not Adolescents

(Reuters) Mar 19, 2015 - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough for adults with asthma to use but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.
read article 

Prothena Reports Positive Results For Parkinson’s Treatment in Early-Stage Study

(Wall Street Journal) Mar 19, 2015 - Prothena Corp. said its Parkinson's disease treatment showed the ability to safely reduce a key protein potentially linked to the disease, in an early stage study.
read article (paid subscription required) 

Biogen Reports Its Alzheimer’s Drug Sharply Slowed Cognitive Decline

(New York Times) Mar 20, 2015 - An experimental drug for Alzheimer’s disease sharply slowed the decline in mental function in a small clinical trial, researchers reported Friday, reviving hopes for an approach to therapy that until now has experienced repeated failures.
read article 

Details and Context of New Payment Models Are Critical to Efforts of Physician Practices to Improve Care, Study Finds

(AMA) Mar 19, 2015 - Physician practices are engaging in new health care payment models intended to improve quality and reduce costs, but are finding that they need help with successfully managing increasing amounts of data and figuring out how to respond to the diversity of programs and quality metrics from different payers, according to a new joint study by the RAND Corporation and the American Medical Association.
read press release 

Dr. Elizabeth Jaffee Honored With AACR-Joseph Burchenal Award for Clinical Cancer Research

(AACR) Mar 19, 2015 - The American Association for Cancer Research (AACR) will honor Elizabeth M. Jaffee, MD, deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, with the 20th annual AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
read press release 

Smartwatches Might Cause Cancer, Says Article Based on ‘Expert’ Who Pushes Holistic Breast Cancer Treatments

(Washington Post/Speaking of Science) Mar 19, 2015 - Fitbits probably won't give people tumors, but articles like the one The New York Times ran this week might give me an ulcer.
read article (free registration required)